FORM 8-K

Company

Arbutus Biopharma Corp

Filed

June 25, 2025

Period of Report

June 20, 2025

Accession Number

0001171843-25-004094

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →